Source Bioscience LifeSciences Aquires imaGenes GmbH
News Dec 07, 2010
imaGenes is a premier provider of genome research services and products in Europe, managing a comprehensive clone collection and offering an exciting range of services including microarray, protein arrays and DNA sequencing. imaGenes’ high end bioinformatic expertise complement the Group’s investment in leading edge next generation sequencing.
Dr Nick Ash, CEO of Source BioScience, said: “The acquisition of imaGenes provides a platform for increased penetration of the European life science research and healthcare markets, acting as a catalyst for accelerated growth. The imaGenes team will bring significant depth of experience and knowledge to the Group and we will be able to leverage their existing links with academic centres and research institutions across Europe.”
Have you ever been stressed out by the idea of doing math or statistics problems? You’re not alone. A new study has used a questionnaire and an analytical technique called "network science" to determine precisely what factors contribute to this kind of statistics anxiety among psychology majors.
Anxiety and depression are surprisingly common among young children. But it can be hard to detect these conditions, known as “internalizing disorders,” because the symptoms are so inward-facing that parents, teachers and doctors often fail to notice them. Now, researchers have developed a tool that could help screen children for internalizing disorders to catch them early enough to be treated.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019